EP1221966 - Bibliographic data
USE OF A PARATHYROID HORMONE FOR REDUCING THE RISK OF CANCER
| Last update | 05/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
Société ELI LILLY AND COMPANY Lilly Corporate Center
Indianapolis, IN 46285
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
HOCK, Janet, M. 7702 Candlewood Lane
Indianapolis, IN 46250
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient KENT, LINDSEY RUTH ET AL Eli Lilly and Company Limited, European Patent Operations, Lilly Research Centre, Sunninghill Road
Windlesham, Surrey GU20 6PH
Royaume-Uni
|
| (21) Request number | EP00961714.3 |
|---|---|
| (22) Request date | 11/09/2000 |
| (11) Publication number | EP1221966 |
|---|---|
| Publication date | 16/11/2005 |
| (54) Title of the invention | USE OF A PARATHYROID HORMONE FOR REDUCING THE RISK OF CANCER |
|---|---|
| (51) International classification | None |
| International classification (before reform) | , |
| Claimed priority |
(31) Number: 155455 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 7 -
Amount: 83 € -
Due date 02/10/2006
Surtax: 7 - Amount: 16.6 € - Due date 03/04/2007 |
|---|---|
| Last annuity | None |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/4, of 31/12/2005 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 16/11/2005 Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2006 Entrée en période de grâce du brevet d'invention - Legal date 02/10/2006 |